Weight loss injection study for adults with obesity
Part of Hormones & metabolism clinical trials.
This study tests an investigational injection called HRS-4729 to see if it helps people with obesity lose weight. It may offer a new treatment option for those who have been trying to manage their weight with diet and exercise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- Your body mass index (BMI) is between 28 and 40.
- You have been following a diet and exercise plan for at least 3 months, with your weight staying stable (no more than 5 kg change).
- You do not have diabetes or certain other medical conditions that affect weight.
- You have not had cancer in the last 5 years (except for some skin or early-stage cancers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational injection called SYH2069 for weight loss in people who are obese but do not have diabetes. It aims to see if the drug is safe and helps reduce body weight.
This trial tests a new injectable medication called SHR-1179 to see if it is safe and can help with weight loss. It is a placebo-controlled study, meaning some participants receive the drug and others receive an inactive shot, and no one knows which they get.
This study tests a new injectable medication to help adults with obesity or overweight who don't have diabetes lose weight. It involves a reduced-calorie diet and exercise plan, and may offer an effective treatment option for weight management.
This early-phase trial tests the safety and tolerability of a new injection called HRS-5817 in healthy volunteers. It helps researchers understand how the drug moves through the body and what side effects it might have.
This study tests a new medicine, SRSD384, to see if it can help people who are overweight or obese lose weight. It is an early-stage trial, so the focus is on safety and how well the medicine works.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
Hear when a new Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.